curasafehealthcare.com
  • Home
  • About
  • Services
  • Therapeutic Areas
  • Careers
  • Latest News
  • Contact Us
Select Page

CAN DUAL ANTIPLATELET THERAPY BE GIVEN SAFELY IN THE EMERGENCY DEPARTMENT FOR ACUTE COROANRY SYNDROME?

by palligoelme@gmail.com | Jun 26, 2025 | Clinical Trials

​ Conditions: Major Bleeding; Major Adverse Cardiovascular and Cerebrovascular Events (MACCE) Sponsors: Jordan Collaborating Cardiology Group Not yet recruiting Conditions: Major Bleeding; Major Adverse Cardiovascular and Cerebrovascular Events (MACCE) Sponsors:...

Effects of Online Mindfulness Therapy on Pain and Stress in Adults With Chronic Migraine and Adverse Childhood Experiences

by palligoelme@gmail.com | Jun 26, 2025 | Clinical Trials

​ Conditions: Chronic Migraine; Adverse Childhood Experiences; Depression; Anxiety; Headache Disorders Interventions: Behavioral: Online Mindfulness-Based Cognitive Therapy Sponsors: Fundación Cardiovascular de Colombia; Universidad de Santander Not yet...

How do Adults Sexual Offender Against Pre-pubescent Minors Perceive the Notion of Consent Based on the Account of Their Lived Experience ? (SOconsent)

by palligoelme@gmail.com | Jun 25, 2025 | Clinical Trials

​ Conditions: Violence Against Children; Sexual Violence; Consent Interventions: Other: Patient interview Sponsors: University Hospital, Montpellier Not yet recruiting Conditions: Violence Against Children; Sexual Violence; Consent Interventions: Other: Patient...

Interstitial Pneumonitis Associated With EGFR-TKI and Combined With PD-1/PD-L1

by palligoelme@gmail.com | Jun 25, 2025 | Clinical Trials

​ Conditions: Non-Small Cell Lung Cancer (NSCLC) Interventions: Drug: EGFR-TKI; Drug: PD-1/PD-L1 inhibitor; Drug: EGFR-TKI combined with PD-1/PD-L1 Sponsors: Wuhan Union Hospital, China Completed Conditions: Non-Small Cell Lung Cancer (NSCLC) Interventions: Drug:...

A Phase 1 Mass Balance Study of [¹⁴C]SSS17 in Healthy Chinese Males

by palligoelme@gmail.com | Jun 25, 2025 | Clinical Trials

​ Conditions: Healthy Subjects (HS) Interventions: Drug: [14C]SSS17 Sponsors: Shenyang Sunshine Pharmaceutical Co., LTD. Not yet recruiting Conditions: Healthy Subjects (HS) Interventions: Drug: [14C]SSS17 Sponsors: Shenyang Sunshine Pharmaceutical Co., LTD. Not yet...
« Older Entries
Next Entries »

Recent Posts

  • Prospective Lifespan Cohort of Myocardial Infarction
  • Skin Involvement in Dupuytren Surgical Treatment Outcome
  • Frequency of MAFLD and Its Association With Nutritional Status and Metabolic Risk Factors in a Rural Population of Bangladesh
  • Piloting a Learning Collaborative for School-Based Bilingual Providers Delivering Evidence-Based Interventions
  • Vorasidenib Guided by AGX PET in Recurrent/Low-grade Glioma

Recent Comments

No comments to show.

Curasafe healthcare solutions Pvt. Ltd. provides comprehensive services including safety program oversight, risk management, and regulatory compliance.

Important Links

  • Home
  • Contact Us
Connect With Us

Contact


711, Shivalik Satyamev, Bopal Ambli Junction, Bopal, Ahmedabad, Daskroi, Gujarat, India, 380058.


info@curasafehealthcare.com



(+91) 97803 81065

Copyright © 2025 Curasafehealthcare ®